Improving Drug Development Requires More Data Sharing – AAMC/FDA Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Developing new mechanisms to share data across industry, FDA, NIH and academia will be vital to improving drug development, says a report summary of January meeting.